Radiopharm Theranostics (ASX:RAD) ROE % Adjusted to Book Value : -70.39% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics ROE % Adjusted to Book Value?

Radiopharm Theranostics's ROE % for the quarter that ended in Dec. 2024 was -70.39%. Radiopharm Theranostics's PB Ratio for the quarter that ended in Dec. 2024 was 1.00. Radiopharm Theranostics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -70.39%.

Radiopharm Theranostics ROE % Adjusted to Book Value Historical Data

The historical data trend for Radiopharm Theranostics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics ROE % Adjusted to Book Value Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

-79.00

-80.60

-213.32

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-104.05	-124.25	-171.37	-278.47	-70.39

Competitive Comparison of Radiopharm Theranostics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Radiopharm Theranostics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Radiopharm Theranostics ROE % Adjusted to Book Value Calculation

Radiopharm Theranostics's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-132.26%	/	0.62
	=	-213.32%

Radiopharm Theranostics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-70.39%	/	1.00
	=	-70.39%

Radiopharm Theranostics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

RADX:USA RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Radiopharm Theranostics Headlines

No Headlines